How much funding has AirXpanders raised?

AirXpanders has raised $8.0M in total funding, most recently a Series C round.

When was AirXpanders founded?

AirXpanders was founded in 2005.

Where is AirXpanders headquartered?

AirXpanders is headquartered in Palo Alto, California, United States.

What industry is AirXpanders in?

AirXpanders operates in Femtech, Medical Devices.

How many employees does AirXpanders have?

AirXpanders has 11-50 employees.

AirXpanders

Patient-controlled breast reconstruction

Palo Alto, United States · Founded 2005 · $8.0M raised

Femtech

Medical Devices

Headquarters: Palo Alto, California
Employees: 11–50
Founded: 2005
Business Model: B2B

Website: airxpanders.com
Total Funding: $8.0M
Last Round: $8.0M Series CFeb 2011
Rounds: 1

About

AirXpanders, Inc. was a Palo Alto, California-based medical device company founded in 2005 focused on improving breast reconstruction outcomes for women following mastectomy. The company developed and commercialized the AeroForm Tissue Expander System — the world's first needle-free, patient-controlled tissue expansion device using carbon dioxide. Unlike traditional saline expanders that require repeated clinic visits for needle injections, AeroForm allowed patients to control their own expansion via a wireless remote. AirXpanders received regulatory approval in Australia (2013) and the United States (FDA 510(k) clearance) and listed on the Australian Securities Exchange (ASX: AXP) via a A$36.5M IPO in 2015. The company raised additional capital in 2017 via a A$45M private placement. Despite clinical success and commercial launch, AirXpanders filed for Chapter 7 bankruptcy due to commercial challenges.

Summary

AirXpanders is a Femtech company based in Palo Alto, United States, founded in 2005. It has raised $8.0M in total across 1 round, most recently a $8.0M Series C round in Feb 2011.